| # | Drug | Count |
|---|---|---|
| 0 | USTEKINUMAB | 16 |
| 1 | METHOTREXATE SODIUM | 15 |
| 2 | SECUKINUMAB | 15 |
| 3 | METHOTREXATE | 14 |
| 4 | INFLIXIMAB | 12 |
| 5 | ADALIMUMAB | 11 |
| 6 | ADALIMUMAB-AATY | 11 |
| 7 | ADALIMUMAB-ADAZ | 11 |
| 8 | ADALIMUMAB-FKJP | 11 |
| 9 | ABATACEPT | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LULICONAZOLE | 1 | 0.0057 |
| 1 | BRODALUMAB | 7 | 0.0034 |
| 2 | CEFIXIME | 4 | 0.0013 |
| 3 | PURIXAN | 1 | 0.0013 |
| 4 | SAW PALMETTO | 1 | 0.0005 |
| 5 | IMIPENEM AND CILASTATIN SODIUM | 1 | 0.0005 |
| 6 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 2 | 0.0004 |
| 7 | ZIDOVUDINE | 4 | 0.0004 |
| 8 | INOTUZUMAB OZOGAMICIN | 1 | 0.0003 |
| 9 | ABACAVIR SULFATE | 3 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17 Receptor A Antagonist [EPC] | 7 | 0.0034 |
| 1 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 2 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 3 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 1 | 0.0002 |
| 4 | Interleukin-12 Antagonist [EPC] | 16 | 0.0002 |
| 5 | Interleukin-23 Antagonist [EPC] | 16 | 0.0002 |
| 6 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 7 | Antimalarial [EPC] | 1 | 0.0001 |
| 8 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |